Skip to main content
OpenTrials
Completed

NCT Number: NCT01424254

The Effectiveness of Video-capsule Endoscopy in Gastrointestinal Bleeding of Obscure Origin

The study objective is to compare the cost-effectiveness of VCE to push enteroscopy in patients with gastrointestinal bleeding of obscure origin with a negative initial work-up.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Montreal General Hospital

Montreal, Quebec, H3G1A4, Canada

About this study

Background: The introduction of the wireless capsule endoscopy (WCE) may dramatically alter the management of patients with small bowel disease such as chronic gastrointestinal bleeding of obscure origin (CGB). Yet, to date, this non invasive technique has undergone widespread diffusion in the absence of properly designed prospective comparative cost-effectiveness evaluations.

Objectives: To examine the clinical impact and cost-effectiveness of a novel approach employing WCE compared to that of push enteroscopy (PE).

Hypothesis: WCE is more cost-effective than PE in patients with CGB. Study design: We propose a randomized clinical trial comparing WCE to PE. Study population: Patients with CGB having undergone initial normal assessment with gastroscopy, colonoscopy and radiological examination of the small bowel.

Outcomes: Primary objective: To compare the detection rates of "clinically significant" small bowel lesions using WCE versus PE in CGB patients randomized to either modality. Secondary objectives: To determine the "cure rate" for each technique after 6 months, the cost-effectiveness of WCE versus PE, the type of small bowel lesions most likely to impact on clinical care, inter-rater variability in reading WCE examinations, the feasibility of WCE interpretation by a dedicated technician, the safety of each imaging modality, and to compare patient satisfaction and quality of life between the two groups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 18 years old
  • Normal gastroscopy, colonoscopy and small bowel follow through in the last 3 months

Exclusion criteria

  • Demonstrable source of blood outside the GI tract
  • Significant cardiopulmonary disease
  • Suspicion of strictures or fistulae of the GI tract
  • Pregnancy
  • Numerous small intestinal diverticula
  • Zenker's diverticulum
  • Extensive Crohn's enteritis

Treatment and study plan

Capsule GIVEN IMAGING

Device

Injection of Capsule Endoscopy

Push-Enteroscopy

Procedure

currently recommended standard

Primary outcomes

  1. The primary outcome measure is the detection rate of clinically significant lesions thought to be responsible for the patients with gastrointestinal bleeding of obscure origin

    Time frame: 12 months

Secondary outcomes

  1. resolution of the anemia/recurrent bleeding

    Time frame: 12 months

  2. blood transfusion requirements

    Time frame: 12 months

  3. Number of required imaging tests (i.e: gastroscopy, colonoscopy, etc)

    Time frame: 12 months

  4. hospitalization/length of stay

    Time frame: 12 months

  5. days away from usual activities (protocol unrelated)

    Time frame: 12 months

  6. patient satisfaction

    Time frame: Following procedure at randomization

    Patient satisfaction questionnaire

Sponsors and collaborators

Lead sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Other

Collaborators

  • American College of Gastroenterology
  • American Society for Gastrointestinal Endoscopy
  • Canadian Institutes of Health Research (CIHR)

Registry information

Important dates

Study start
2003
Primary completion
2010
Study completion
2011
First posted
Aug 26, 2011
Registry last updated
Aug 26, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.